|
Dr. Galakatos is a co-founder and Managing Director of Clarus Ventures. He has over 21 years of industry and investment experience in the healthcare sector, including being a General Partner at MPM Capital since 2000. From 1997 to 2000, Dr. Galakatos was Vice President of New Business at Millennium Pharmaceuticals and a member of the Management Team. Prior to Millennium he was at Venrock Associates and Novartis (formerly Ciba) where he was Head of Molecular Biology Research. Dr. Galakatos was a co-founder of Millennium Predictive Medicine, and TransForm Pharmaceuticals, where he was also Chairman. He holds a Ph.D. degree in organic chemistry from MIT, and performed postdoctoral studies in molecular biology at Harvard Medical School. | 